Recombinant Human IL-4

Leinco Technologies
Product Code: LEI-I-186
Product Group: Recombinant Proteins
CodeSizePrice
LEI-I-186-10ug10 ug£420.00
Quantity:
LEI-I-186-20ug20 ug£534.00
Quantity:
LEI-I-186-50ug50 ug£1,126.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO
Shipping:
Ambient
Storage:
This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions.

Further Information

Format:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives present.
Formulation:
This recombinant protein was 0.2 um filtered and lyophilized from modified Dulbecco?s phosphate buffered saline (1X PBS) pH 7.2 ? 7.3 with no calcium, magnesium, or preservatives present.
Long Description:
IL-4 is a 15-19 kD pleiotropic immune cytokine secreted by activated TH2 cells. It has many biological roles, including the regulation in humoral and adaptive immunity, the inhibition of bone resorption, the stimulation of activated B-cell and T-cell proliferation, and initiation of allergic responses. Moreover, IL-4 induces a positive feedback loop by stimulating differentiation of naive helper T cells, or Th0 cells, to Th2 cells which in turn secrete more IL-4. Increased IL-4 production and overproduction of IL-4R are found in many cancers. IL-4 has a significant effect on tumor progression by increasing apoptosis resistance via tumor growth enhancement. IL-4 may also play a part in the immune dysregulation that occurs in most HIV-1 infected patients.
NCBI Gene:
3565
Purity:
>97% by SDS-PAGE and analyzed by silver stain.
Target:
IL-4

References

1. ?dum, N. et al. (2001) Blood. 97(4):1056-62. Article Link 2. ?dum, N. et al. (2003) J Biol Chem. 278(5):2787-91. Article Link 3. ?dum, N et al. (2001) Leukemia 15:787?793 Article Link 4. Woetmann, A. et al. (2010) Experimental Dermatology 19:1096?1102. Article Link 5. Pike, JW. et al. (2001) PNAS 98:2443 6. Finkelman, FD. et al. (2003) J. Immunol. 170:3835 7. Paludan, SR. et al. (1998) Scand. J. Immunol. 48:459 8. Ryan, JJ. et al. (2007) Crit. Rev. Immunol. 27:15

Related Products

Product NameProduct CodeSupplier 
Anti-Human IL-4LEI-I-148Leinco Technologies Summary Details
Anti-Mouse IL-4LEI-I-164Leinco Technologies Summary Details
Anti-Human IL-4 (Clone 3010)LEI-I-173Leinco Technologies Summary Details
Recombinant Mouse IL-4LEI-I-207Leinco Technologies Summary Details
Recombinant Rat IL-4LEI-I-221Leinco Technologies Summary Details
Anti-Rat IL-4LEI-I-225Leinco Technologies Summary Details
Anti-Human IL-4 - BiotinLEI-I-251Leinco Technologies Summary Details
Anti-Mouse IL-4 - BiotinLEI-I-252Leinco Technologies Summary Details
Anti-Rat IL-4 - BiotinLEI-I-253Leinco Technologies Summary Details
Anti-Human IL-4 (Clone 34019)LEI-I-631Leinco Technologies Summary Details
Anti-Mouse IL-4 (Clone 30340)LEI-I-662Leinco Technologies Summary Details
Anti-Rat IL-4 (Clone 56567)LEI-I-673Leinco Technologies Summary Details
Anti-Porcine IL-4LEI-I-689Leinco Technologies Summary Details